Market Place
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations. 
X
Please Wait
Applying Filters...
01 Dr. Reddy's Laboratories (5)
02 Medichem S.A (2)
03 Accord healthcare (3)
04 Aspiro Pharma (2)
05 Aurobindo Pharma Limited (1)
06 Baxter Healthcare Corporation (5)
07 Biological E (4)
08 CUBIST PHARMS INC (4)
09 DR REDDY'S LABORATORIES LTD (1)
10 Deva Holding AS (2)
11 Fresenius Kabi USA, LLC (1)
12 Hainan Poly Pharm (3)
13 Hangzhou Zhongmei Huadong Pharmaceutical (1)
14 Health Biotech (2)
15 Hospira, Inc. (4)
16 Jiangsu Hengrui Medicine (2)
17 Kaliberr Labs (1)
18 Meitheal Pharmaceuticals (2)
19 Merck & Co (6)
20 Olon S.p.A (2)
21 Qilu Pharmaceutical (1)
22 Sagent Pharmaceuticals (2)
23 Sandoz B2B (1)
24 Teva Pharmaceutical Industries (1)
25 Viatris (2)
26 Xellia Pharmaceuticals ApS (6)
27 Zhejiang Hisun Pharmaceutical (1)
01 Powder for Solution (Lyophilized Powder) (2)
02 Daptomycin 350Mg 1 Unit Parenteral Use (1)
03 Daptomycin 500Mg 10Ml 1 Units Parenteral Use (1)
04 INF (1)
05 INJ (1)
06 Injection (6)
07 Lyophilizate (2)
08 Lyophilized Injection (2)
09 POWDER FOR SOLUTION (4)
10 POWDER;INTRAVENOUS (34)
11 Powder for Injection (2)
12 Powder for injection/infusion fluid, resolution (1)
13 SOLUTION;INTRAVENOUS (4)
14 Vial (4)
15 Blank (2)
01 Available Dossier- US-EU-RoW (1)
02 DISCN (5)
03 Generic (5)
04 Lead Market Dossiers- Filed (2)
05 Originator (1)
06 Prescription (4)
07 RX (32)
08 Blank (17)
01 CUBICIN (2)
02 CUBICIN RF (2)
03 Cubicin (4)
04 DAPTOMYCIN (30)
05 DAPTOMYCIN FOR INJECTION (3)
06 DAPTOMYCIN IN 0.9% SODIUM CHLORIDE (4)
07 DAPZURA RT (1)
08 Drymred 500 (1)
09 Blank (20)
01 Canada (4)
02 China (3)
03 Denmark (2)
04 India (7)
05 Italy (4)
06 Norway (1)
07 South Africa (2)
08 Spain (2)
09 Switzerland (2)
10 Turkey (2)
11 USA (38)
